2,130 results on '"Drenth, Joost"'
Search Results
2. Detection of polyreactive immunoglobulin G facilitates diagnosis in children with autoimmune hepatitis
3. Recommendations for the safe use of direct oral anticoagulants in patients with cirrhosis based on a systematic review of pharmacokinetic, pharmacodynamic and safety data
4. Recurrences of advanced sessile and lateral spreading colorectal adenoma after endoscopic mucosal resection (EMR) thermal ablation versus no adjuvant therapy (RESPECT): a protocol of an international randomized controlled trial
5. Tacrolimus versus mycophenolate for AutoImmune hepatitis patients with incompLete response On first-line therapy (TAILOR study): a study protocol for a phase III, open-label, multicentre, randomised controlled trial
6. Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
7. Efficacy and safety of palliative treatment in patients with autoimmune liver disease-associated hepatocellular carcinoma
8. Clinical management of liver cyst infections: an international, modified Delphi-based clinical decision framework
9. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients
10. Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study
11. Diagnostic criteria and long-term outcomes in AIH-PBC variant syndrome under combination therapy
12. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease
13. Standard of Care Versus Octreotide in Angiodysplasia-Related Bleeding (the OCEAN Study): A Multicenter Randomized Controlled Trial
14. An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis
15. Validation of a semi-automatic method to measure total liver volumes in polycystic liver disease on computed tomography — high speed and accuracy
16. Evaluation of Tofacitinib in Primary Sclerosing Cholangitis and Associated Colitis: A Multicenter, Retrospective Study
17. Persistent and new-onset symptoms after cholecystectomy in patients with uncomplicated symptomatic cholecystolithiasis: A post hoc analysis of 2 prospective clinical trials
18. A mixed-methods study to define Textbook Outcome for the treatment of patients with uncomplicated symptomatic gallstone disease with hospital variation analyses in Dutch trial data
19. Suspected common bile duct stones: reduction of unnecessary ERCP by pre-procedural imaging and timing of ERCP
20. Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease
21. Expanding the clinical application of the polycystic liver disease questionnaire: determination of a clinical threshold to select patients for therapy
22. Issues in multi-organ transplantation of the liver with kidney or heart in polycystic liver-kidney disease or congenital heart disease: Current practices and immunological aspects
23. Genetics, pathobiology and therapeutic opportunities of polycystic liver disease
24. Complications of percutaneous transhepatic cholangiography and biliary drainage, a multicenter observational study
25. Prostaglandin E2, Osmoregulation, and Disease Progression in Autosomal Dominant Polycystic Kidney Disease
26. WED-160 Autoantibody diagnostics in pediatric non-viral liver diseases: a multicenter retrospective head-to-head comparison of immunofluorescence- and enzyme-linked immunosorbent assay-based testing
27. THU-138 The male-to-female ratio among patients with primary biliary cholangitis depends on age
28. OS-015 Time to complete biochemical response and disease progression in autoimmune hepatitis
29. Incidence and prevalence of primary biliary cholangitis in the Netherlands – a nationwide cohort study
30. THU-100 Factors associated with the real-world biochemical response to fibrate therapy in primary biliary cholangitis
31. THU-115-YI Ursodeoxycholic acid treatment for primary sclerosing cholangitis
32. THU-120-YI The impact of ursodeoxycholic acid on biochemistry of patients with primary biliary cholangitis in a nationwide cohort
33. Polycystic liver: automatic segmentation using deep learning on CT is faster and as accurate compared to manual segmentation
34. EASL Clinical Practice Guidelines on the management of cystic liver diseases
35. Hepatitis C Elimination in the Netherlands (CELINE): How nationwide retrieval of lost to follow-up hepatitis C patients contributes to micro-elimination
36. Implementation of a decentralized hepatitis C care pathway for people who use drugs in Dutch addiction care. Study protocol for the Hepatitis C: chain of addiction care (CAC) project
37. Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial
38. The present and future of gastroenterology and hepatology: an international SWOT analysis (the GASTROSWOT project)
39. Validation of the enhanced liver fibrosis (ELF)-test in heparinized and EDTA plasma for use in reflex testing algorithms for metabolic dysfunction-associated steatotic liver disease (MASLD).
40. Defective Lipid Droplet–Lysosome Interaction Causes Fatty Liver Disease as Evidenced by Human Mutations in TMEM199 and CCDC115
41. Budget Impact of Restrictive Strategy Versus Usual Care for Cholecystectomy (SECURE-Trial)
42. Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients
43. Sex, Genotype, and Liver Volume Progression as Risk of Hospitalization Determinants in Autosomal Dominant Polycystic Liver Disease
44. The pathophysiology of polycystic liver disease
45. Prednisolone with azathioprine or mycophenolate mofetil as first-line therapy in autoimmune hepatitis: insights from a randomized controlled trial
46. Effectiveness and predictors of response to somatostatin analogues in patients with gastrointestinal angiodysplasias: a systematic review and individual patient data meta-analysis
47. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis
48. Drug withdrawal in patients with autoimmune hepatitis in long-term histological remission: A prospective observational study
49. Histological activity despite normal ALT and IgG serum levels in patients with autoimmune hepatitis and cirrhosis
50. Aggressive fluid hydration plus non-steroidal anti-inflammatory drugs versus non-steroidal anti-inflammatory drugs alone for post-endoscopic retrograde cholangiopancreatography pancreatitis (FLUYT): a multicentre, open-label, randomised, controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.